Jacobson Pharma Corporation Limited (HK:2633) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Jacobson Pharma Corporation Limited reported a robust financial performance for the six months ending September 2024, with a 13.3% increase in revenue to HK$810.0 million and a 44.2% surge in profit from continuing operations to HK$140.3 million. The company also declared a 40% higher interim dividend, reflecting strong growth compared to the same period in 2023. These results highlight the company’s resilient business model and its promising outlook for investors.
For further insights into HK:2633 stock, check out TipRanks’ Stock Analysis page.